Prof. Oo said, "Heart valve replacement therapy presents several post-operative challenges for patients, especially the need for blood thinners and the related risk of bleeding and thrombotic events.
AUSTIN, Texas--(BUSINESS WIRE)--Privately held On-X® Life Technologies Inc. (On-X LTI), whose mechanical heart valves have been implanted in more than 150,000 patients in over 90 countries, announced ...
Austin-based On-X Life Technologies, Inc., which manufactures Prosthetic Heart Valve and carbon products for orthopedic implants, recently announced that it is doubling the size of its manufacturing ...